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Abstract
Background:  To derive an ultrasound-based prediction model for the quantification of
haemoperitoneum in ectopic pregnancy (EP).
Methods: Retrospective study of 89 patients operated upon EP between January 1999 and March
2003 in a French Gynaecology and Obstetrics department in a university hospital. Transvaginal
sonograms, clinical and biological variables from patients with haemoperitoneum ≥ 300 ml at
surgery were compared with those from patients with haemoperitoneum < 300 ml or no
haemoperitoneum. Sensitivity, specificity, positive and negative likelihood ratios were calculated for
each parameter after appropriate dichotomization. Multiple logistic regression analysis was used to
select the best combination at predicting haemoperitoneum ≥ 300 ml.
Results: Three parameters predicted haemoperitoneum ≥ 300 ml independently:  moderate to
severe spontaneous pelvic pain, fluid above the uterine fundus  or around the ovary at transvaginal
ultrasound, and serum haemoglobin concentration < 10 g/dL. A woman with none of these three
criteria would have a probability of 5.3% for haemoperitoneum ≥ 300 ml. When two or more
criterias were present, the probability for haemoperitoneum ≥ 300 ml reached 92.6%.
Conclusion: The proposed model accurately predicted significant haemoperitoneum in patients
diagnosed to have EP.
Background
The combination of transvaginal ultrasound (US) and
serum human chorionic gonadotropin (hCG) determina-
tion has proven to be reliable for the early diagnosis of
ectopic pregnancy (EP) [1-4]. The goal of early diagnosis
is the prevention of tubal rupture [5], which is the cause
of most EP-related deaths [6,7], and is a surgical emer-
gency. Accordingly, suspicion of tubal rupture is an abso-
lute contraindication for medical treatment of EP using
methotrexate [8-12].
Although, the diagnosis of tubal rupture is obvious when
patients are haemodynamically unstable, symptoms in
most cases of tubal rupture are more subtle [13-16]. The
only diagnostic method to rule out tubal rupture would
be to perform a laparoscopy in all cases [15].
Published: 7 September 2007
World Journal of Emergency Surgery 2007, 2:23 doi:10.1186/1749-7922-2-23
Received: 19 February 2007
Accepted: 7 September 2007
This article is available from: http://www.wjes.org/content/2/1/23
© 2007 Fauconnier et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.World Journal of Emergency Surgery 2007, 2:23 http://www.wjes.org/content/2/1/23
Page 2 of 7
(page number not for citation purposes)
However, considering that most tubal rupture would
cause significant haemoperitoneum and that the latter
would often correspond to tubal rupture is clinically
sound. Evidence for haemoperitoneum is usually found
on US examination. Nevertheless, the various US criteria
used to quantify the amount of the haemoperitoneum
prior to surgery [12,17-21] have not been validated yet.
The aim of our study was therefore to identify criterias in
the pre operative work-up that could be useful to predict
the haemoperitoneum volume, in a homogeneous series
of patients operated upon EP.
Methods
Study population
All patients assigned for surgical treatment for EP between
January 1999 and March 2003, by laparoscopy or by
laparotomy, were included in the study.
The patients were identified from the hospital's computer-
ized Medical Information System. The indication for sur-
gical treatment of EP was left to the attending consultant
gynaecologist, and surgery took place either at the time of
presentation or after failure of medical treatment using
methotrexate. At our institution medical treatment is
offered on the basis of: absence of significant pain and sta-
ble hemodynamics, normal serum haemoglobin concen-
tration and white cell count as well as serum hCG
concentration < 5000 IU/L; patient accepting the medical
treatment and its follow-up.
Variables of interest
The following parameters were collected from the medical
records: age, gravidity, parity, gestational age, the exist-
ence of vaginal bleeding, the existence and severity of
spontaneous pelvic pain, systolic and diastolic blood
pressure, pulse rate, pre operative serum haemoglobin
concentration (g/dL) and pre operative serum hCG con-
centration (UI/L). All these parameters were collected at
presentation. The severity of spontaneous pelvic pain was
subjectively assessed by the specialist registrar, in a semi-
quantitative fashion using four levels: absent, mild, mod-
erate, or severe [22].
Transvaginal US investigation was carried out pre opera-
tively in all cases by the registrar or the consultant. One of
three US machines were used: a Voluson® 530D MT, fitted
with a 7.5 MHZ convex transvaginal probe S-EW5/7K
(Kretztechnik AG), a Logic 700, fitted with a 5.6 MHZ
convex transvaginal probe 618E (GE Medical System),
and a Logic 500 fitted with a 4.8 MHZ convex transvaginal
probe E721 (GE Medical System). It is the policy in our
institution to record images of a standardised sonogram
in cases with EP. At least, three pictures are requested: one
of the uterus in a stricly midsagittal plane from the uterine
cervix to the fundus; one of each ovary in there greater
diameter. In case of abnormal extra-uterine finding one or
more picture were requested. All sonograms were carefully
reviewed for the study, in order to ensure a standardised
analysis of the characteristics of intraperitoneal effusion.
All ultrasound records were reviewed by one trained spe-
cialist registrar (AM) under the direct supervision of a sen-
ior operator skilled in the practice of gynaecological
ultrasound (J-PB). This review was carried out blindly to
the quantification of haemoperitoneum as stated in the
surgery report. The presence of free fluid in the Pouch of
Douglas was defined by the presence of liquid behind the
uterus on a strictly midsagittal plane. The volume of the
intraperitoneal fluid was assessed in semi-quantitative
way according to the level reached relative to the uterus on
a midsagittal plane: (i) below or at the level of the uterine
isthmus; (ii) reaching the uterine body; (iii) exceeding the
uterine fundus. This classification was adapted from
another study [18]. Fluid around the ovary or in the
vesico-uterine pouch was also noted. The fluid was
described as echogenous if fine, diffuse echos were visible
in the liquid [23,24], and the presence of clots was noted
if there were heterogeneous areas within the fluid [25].
A quantitative estimate of the haemoperitoneum in ml,
was carried out during surgery by recording of the volume
aspirated and irrigation fluid. Presence or absence of tubal
rupture was also noted.
Statistical analysis
The study population was split into two groups according
to the volume of the haemoperitoneum found at surgery:
one group of patients with a haemoperitoneum volume
quantified equal to or above the median volume; one
group of patients with no haemoperitoneum or below the
median volume.
The two groups were compared using Pearson's Chi-
Square test for qualitative variables and Student's t test for
quantitative variables. The continuous and ordinal varia-
bles found to be associated with haemoperitoneum equal
to or above the median volume at a threshold of p < 0.10
in the univariate analysis were then dichotomised to ena-
ble their use in a prediction model. The diagnostic value
of each variable was estimated by calculating the sensitiv-
ity (Se), specificity (Sp), positive likelihood ratio (LR) and
negative LR. When a variable presented several possible
cut-off levels, the one chosen was either that which gave
maximum Se or maximum Sp [26].
Multiple logistic regression analysis was then used in
order to select the best combination of variables to predict
the presence of a haemoperitoneum equal to or above the
median volume. The condition for variables to be
included in the logistic regression model was the fact ofWorld Journal of Emergency Surgery 2007, 2:23 http://www.wjes.org/content/2/1/23
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presenting a sufficiently high diagnostic value: negative
LR ≤ 0.25 for variables with high sensitivity [26]; or posi-
tive LR ≥ 4 for variables with high specificity [26]. A back-
ward stepwise procedure was then used to remove
variables so that the final model included only those var-
iables independently associated with haemoperitoneum
equal to or above the median volume at a threshold of p
< 0.05.
The variables thus selected were then combined with each
other and the diagnostic performance of each of the vari-
ous combinations for prediction of haemoperitoneum
equal to or above the median volume was assessed by cal-
culating Se, Sp, positive and negative LR on the basis of
the patients in our sample population.
Analyses were carried out using the version 5.0 Statview
statistics software package (SAS Corporation).
Results
During the study period 119 patients were operated upon
EP, of whom 30 (25.2%) were excluded, as no adequate
US image were available (N = 15) or when the haemoper-
itoneum had not been measured intraoperatively (N =
15). This left 89 patients to constitute the study popula-
tion. Baseline characteristics of the population are shown
in Table 1.
The median volume of the haemoperitoneum measured
at the time of surgery was 300 ml. Forty eight (53.9%)
patients presented haemoperitoneum ≥ 300 ml and 41
patients (46.1%) presented no haemoperitoneum or <
300 ml (Table 1). Thirty eight patients had tubal rupture
(40.4%). The proportion of ruptured tubes was markedly
higher among patients with a haemoperitoneum ≥ 300 ml
(60.4 versus 17.1%; p < 0.0001).
The crude associations between the studied variables and
the existence of massive haemoperitoneum are summa-
rised in Table 2. There was a linear trend between the vol-
ume of intraperitoneal fluid at transvaginal sonogram of
the uterus and the probability of haemoperitoneum ≥ 300
ml at surgery: indeed, 83.3% of patients with fluid above
the uterine fundus, 70.6 with fluid reaching the uterine
body and 24.3% with fluid under the uterine isthmus or
absent had haemoperitoneum ≥ 300 ml respectively (Chi-
square for linear trend = 20.9 with 1 degree of freedom; p
< 0.0001).
The diagnostic values of the variables associated with hae-
moperitoneum ≥ 300 ml in the univariate analysis are
shown in Table 3. Three variables had a high sensitivity
with sufficiently low negative LR: any pelvic pain, moder-
ate to severe pelvic pain, and the presence of any amount
of fluid in the pouch of Douglas (Table 3). Four variables
a had high specificity and sufficiently high positive LR: a
serum haemoglobin concentration < 10 g/dl, a systolic
blood pressure < 100 mm Hg, fluid above the uterine fun-
dus, and fluid around the ovary (Table 3). As the latter two
variables were not inter-connected (Chi-square with 1
degree of freedom = 1.1; p = not significant) and each rep-
resented a small number of patients, they were combined
into a single variable: fluid above the uterine fundus OR
fluid around the ovary.
These variables were all introduced into a multiple regres-
sion analysis model. After using the selection procedure,
three variables independently predicted the finding of a
haemoperitoneum  ≥ 300 ml at surgery: moderate to
severe pelvic pain, fluid above the uterine fundus OR fluid
around the ovary, and a serum haemoglobin concentra-
Relationship between the amount of haemoperitoneum  (expressed in percentile) and the three variables used in the  model Figure 1
Relationship between the amount of haemoperitoneum 
(expressed in percentile) and the three variables used in the 
model.
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Table 1: Characteristics of the study population (N=89)
variables n Mean ± 1 SD Frequency 
(%)
Age (years) 30.2 ± 5.0
Gravidity 2.9 ± 1.6
Gestational age (days) 32.9 ± 16.2
Laparoscopy
From outset 76 85.4
Methotrexate failure 11 12.4
Laparotomy 2 2.2
Tubal rupture 36 40.4
Haemoperitoneum (mL)
<60 21 23.6
[60–300] 20 22.5
[300–900] 37 41.6
≥ 900 11 12.3
SD = standard deviationWorld Journal of Emergency Surgery 2007, 2:23 http://www.wjes.org/content/2/1/23
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tion < 10 g/dL (Table 4). Although Serum hCG < 5000
had no interesting diagnostic value (Table 3) it was still
included in the multiple regression analysis model in
order to avoid any confusion bias. Indeed the Serum hCG
concentration was used to select patients who may
undergo medical therapy.
Assessment for the best combination of these three varia-
bles is given in Table 5. Given a 53.9% prevalence of hae-
moperitoneum  ≥ 300 ml in the overall population, a
patient with none of the three criteria would have a prob-
ability of 5.3% for a haemoperitoneum ≥ 300 ml.
Inversely when two or more criteria are present, the prob-
ability for a haemoperitoneum ≥ 300 ml is in between
92.6 and 100.0%.
Relations between the quantification of haemoperito-
neum, expressed in percentile, and the three variables of
the model are plotted on figure 1. There is an increasing
relationship between the amount of the haemoperito-
neum and each of the three variable used in the prediction
model.
Discussion
We have developed a clinical prediction model for the
diagnosis of significant haemoperitoneum in patients
with EP. This model was based on three simple and repro-
ducible criteria: The presence of moderate to severe spon-
taneous pelvic pain, the presence of intraperitoneal fluid
above the uterine fundus or around the ovary at transvag-
inal US, and the existence of a serum haemoglobin con-
centration < 10 g/dL. We found that this model may
reliably rule out or confirm preoperatively, the existence
of a significant haemoperitoneum at surgery.
One of the biggest limitations of our study is that it was
retrospective. As an example, assessment of the severity of
the pain was based on the attending phycisian's interpre-
tation of the patient's pain and no strict criteria such as
self-evaluation by a visual analog scale was used [27]. This
Table 2: Characteristics and ultrasound findings according to the haemoperitoneum volume at surgery
Variables Haemoperitoneum<300 ml N 
= 41
Haemoperitoneum≥300 ml 
N = 48
P value
Mean ± 1 SD Mean ± 1 SD
Age (year) 30.8 ± 5.5 29.7 ± 4.7 0.301*
Number of previous pregnancies 3.0 ± 1.8 2.9 ± 1.6 0.718*
Parity 1.2 ± 1.2 1.0 ± 0.9 0.400*
Gestional age (day) 34.7 ± 15.5 31.3 ± 16.9 0.336*
No (%) No (%)
Vaginal bleeding 33 (80.4) 30 (62.5) 0.063*
Spontaneous pelvic pain
Absent 7 (17.1) 0 (0)
Mild 13 (31.7) 4 (8.3) <0.001†
Moderate 12 (29.3) 19(39.6)
Severe 9 (21.9) 25 (52.1)
Mean ± 1 SD Mean ± 1 SD
Systolic blood pressure (mmHg) 119.5 ± 11.7 113.3 ± 15.3 0.038*
Diastolic blood pressure (mmHg) 72.4 ± 8.9 66.7 ± 10.0 0.006*
Heart rate (pulse/mn) 83.8 ± 13.8 85.5 ± 12.3 0.530*
Serum hCG concentration (UI/L) 7412 ± 11667 3828 ± 6465 0.068*
Serum haemoglobin concentration (g/dl) 12.0 ± 1.2 10.5 ± 1.9 <0.001*
Volume of intraperitoneal fluid at TVUS No (%) No (%)
Absent 11 (26.8) 4 (8.3%)
≤ Uterine isthmus 17 (41.5) 5 (10.4%) <0.001†
Uterine body 10(24.4) 24(50.0%)
> Uterine fundus 3 (7.3) 15(31.3%)
Clots present at TVUS 12 (29.3) 35 (72.9) <0.001†
Fluid around the ovary at TVUS 1 (2.4) 8 (16.7) 0.027†
Fluid in the vesico-uterine pouch at TVUS 5 (12.8) 5 (10.6) 0.753†
Mean ± 1 SD Mean ± 1 SD
Height of fluid in Pouch of Douglas (mm ± 1 SD)‡ 20.8 ± 10.2 26.5 ± 12.0 0.039*
Width of fluid in Pouch of Douglas (mm ± 1 SD)‡ 29.3 ± 25.9 50.8 ± 24.3 <0.001*
SD = standard deviation. TVUS = transvaginal ultrasound examination
* Student's t-test.
† Chi square for heterogeneity.
‡ for one woman the measurement was not available.World Journal of Emergency Surgery 2007, 2:23 http://www.wjes.org/content/2/1/23
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may lead to a substantial interobserver difference in
graded pain. There is nonetheless a fair agreement
between physicians and patients' estimates of pain [28].
The quality of US data used in this study relies in the fact
the fact that the information was not gathered from a writ-
ten report in the patient's notes, but that they were
obtained by re-interpreting standardised sonograms blind
to surgical findings. Patients for whom we did not retrieve
standardised transvaginal sonograms were excluded from
the study. Nevertheless, prospective validation studies of
samples from different centres are important to evaluate
the actual predictive ability of a diagnostic model [29].
Although our criteria appeared to be reliable to exclude
the presence of massive haemoperitoneum, there may be
a tubal rupture in the absence of any significant haemo-
peritoneum in up to 27% of the cases [17,30]. However,
this type of tubal rupture is probably unlikely to cause
active bleeding at the time of diagnosis, but secondary
resumption of bleeding could explain some of the failures
observed after treatment by methotrexate, including cases
with no intraperitoneal effusion [11,19]. This was the case
for two patients in our study who had a tubal rupture with
no active bleeding and a haemoperitoneum of 30 ml and
120 ml respectively. Anyway, our model, which was spe-
cifically designed to predict the existence of massive hae-
moperitoneum, is in agreement with a previously
developed model for prediction of tubal rupture or active
bleeding in EP [15]. Indeed, in this model, the three most
important criteria were the existence of an intraperitoneal
effusion at transvaginal US, any spontaneous abdominal
pain and Hb ≤ 9.7 g/dl. The match between this model
and ours confirms the fact that pre operative diagnosis of
tubal rupture is mostly based on the presence of haemo-
peritoneum.
Appropriate quantification of intraperitoneal fluid at US
is important because fluid in the Pouch of Douglas may
be present in up to 80% of EP whether ruptured or not
[17,31]. A semi-quantitative estimate of haemoperitoeum
volume, using transvaginal US examination of the uterus
in a midsagittal plane, which we have used (adapted from
[18]) showed an excellent correlation with the volume of
haemoperitoneum measured during surgery. We elected
to use this classification because it is based on a standard
ultrasound plane that is easy to obtain, and on criteria
that seem reproducible. Two other ultrasound classifica-
tions have been proposed to assess the quantity of haemo-
peritoneum. One author [20] differentiates three classes
of effusion: ≤ 10 ml, 10 ml to 100 ml and > 100 ml, with-
Table 4: Independent predictors of haemoperitoneum ≥ 300 ml 
using multiple regression analysis
Variables Adj. OR* 95% CI
Hb < 10 g/dL
No 1 Ref.
Yes 20.0 1.9–214.1
Spontaneous pelvic pain
None to mild 1 Ref.
Moderate to severe 11.5 2.3–57.2
Fluid > uterine fundus OR fluid around the 
ovary at TVUS
No 1 Ref.
Yes 12.9 2.5–65.5
Hb = Serum haemoglobin concentration. Adj. OR = Adjusted Odds 
Ratio. CI = confidence interval. Ref. = reference class for the variable.
* The variable Serum hCG < 5000 was introduced in the model in 
order to avoid confusion bias
Table 3: Diagnostic value of the variables found to be predictive of haemoperitoneum ≥ 300 ml at univariate analysis at their best cut-
off point
Variable Patients with the characteristic Se(%) Sp(%) LR + LR - p-value*
Vaginal bleeding absent 26 37.5 80.5 1.92 0.78 0.063
Any pelvic pain 82 100.0 17.1 1.21 0.00 0.003
Moderate to severe pelvic pain 65 91.5 48.8 1.8 0.2 <0.001
Systolic blood pressure < 100 mm Hg 12 20.8 95.1 4.27 0.83 0.0215
Hb < 10 g/dl 15 29.2 97.6 11.9 0.73 0.001
Serum hCG < 5000 IU/L 66 83,3 36,6 1,31 0,46 0,032
Any fluid in the pouch of Douglas at TVUS 74 91.7 26.8 1.25 0.31 0.020
Fluid > uterine isthmus at TVUS 52 81.3 68.3 2.56 0.27 <0.001
Fluid > uterine fundus at TVUS 18 31.1 92.7 4.27 0.74 0.005
Fluid arround the ovary at TVUS 9 16.7 97.6 6.83 0.85 0.027
Fluid > uterine fundus OR fluid arround the ovary at TVUS 24 43.8 92.7 5.98 0.61 <0.001
Fluid height ≥ 11 mm at TVUS 65 85.1 39.0 1.40 0.38 0.010
Fluid Width ≥ 20 mm at TVUS 66 89.4 41.5 1.53 0.26 0.001
Clots present at TVUS 47 72.9 70.7 2.5 0.4 <0.001
Hb = Serum haemoglobin concentration. LR + = positive likelihood ratio. LR - = negative likelihood ratio. Se = sensitivity. Sp = specificity. TVUS = 
transvaginal ultrasound examination.
* Chi square for heterogeneity.World Journal of Emergency Surgery 2007, 2:23 http://www.wjes.org/content/2/1/23
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out however setting any precise ultrasound criteria. Others
[21,32] subjectively quantified the amount of intraperito-
neal fluid as small, moderate or large. Although these last
two classifications are often used to predict the haemoper-
itoneum volume prior to medical treatment of EP, they
have never been subjected to a correlation with the vol-
ume found at surgery.
Our clinical model for prediction of massive haemoperi-
toneum may be useful for the medical management of EP.
When none of the three criteria is present, medical treat-
ment and follow-up as an outpatient is, to our opinion,
possible. Accordingly, the model fits well with well-
known countraindications for methotrexate [19] Sowter,
2001; Rozenberg, 2003]. However these contraindica-
tions were so far solely based on clinical opinion. Because
the absence of all three criteria in the population study
was rather uncommon, one may question the usefulness
of the model in clinical practice. Our centre has been sup-
porting medical treatment for EP for the last 10 years
[10,33] and most patients with obvious criterias for med-
ical treatment were unlikely to be selected in the present
study. When used in a more general population of women
with EP, the negative predictive value of our model for the
diagnosis of significant haemoperitoneum is therefore
likely to increase.
Finally, our clinical prediction model should be further
tested and may prove useful to monitor patient with
methotrexate treatment. Indeed, spontaneous pelvic pain
occurs frequently during this treatment. Although in most
cases the outcome is spontaneously favourable, this situa-
tion does raise concerns and often leads to unnecessary
laparoscopy [30,34,35]. Our model may help in the man-
agement of these patients: as increasing haemoperito-
neum at transvaginal US or a drop in haemoglobin
concentration would suggest that laparoscopy should be
performed.
Conclusion
Three criteria may predict massive haemoperitoneum in
EP: moderate to severe spontaneous pelvic pain, fluid
above the uterine fundus or around the ovary at ultra-
sound, and low serum haemoglobin concentration. The
proposed model accurately predicted significant haemo-
peritoneum in patients diagnosed to have EP. It could be
used to select patients who should not undergo medical
treatment. The usefulness of the proposed model should
be tested prospectively as part of routine triage of patients
with suspected EP in the emergency department.
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